Home - Syndax

Determined to realize a future in which people with cancer live longer and better than ever before.

Clinical Trials

08.08.22

Syndax Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Business Update

08.02.22

Syndax to Announce Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 8, 2022

06.16.22

Syndax Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

06.13.22

Syndax Pharmaceuticals Announces Appointment of Keith A. Goldan as Chief Financial Officer